Loading...
Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
Despite the great efforts for better treatment options for diffuse large B-cell lymphoma (DLBCL) (most common form of non-Hodgkin lymphoma, NHL) to treat and prevent relapse, it continues to be a challenge. Here, we present an overview of DLBCL and address the diagnostic assays and molecular techniq...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646825/ https://ncbi.nlm.nih.gov/pubmed/33216822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27785 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|